Cancer Nanotechnology

Basic,Translational and Clinical Research

Cancer Nanotechnology Cover Image

Prostate Cancer

Prostate cancer is the most commonly diagnosed cancer in men. Localized disease is commonly treated with androgen deprivation therapy, surgery or radiotherapy but currently many men develop metastatic castrate resistant prostate cancer.

Novel approaches for early diagnosis and improved therapy are required. This special issue provides a collection of original papers and expert reviews covering a broad range of nanomedical approaches to improving outcomes in prostate cancer.

Nanoparticles have enormous potential to act as radiosensitizers, and targeted therapies are being refined for clinical use with the potential to enhance image guided radiotherapy. Furthermore, many nanoparticles have been designed as drug delivery agents with the promise of delivering increased therapeutic payloads directly to the tumor.

Edited by: Suneil Jain and Helen McCarthy

Deadline for submissions: 31st July 2016

Submission Instructions

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cancer Nanotechnology. The complete manuscript should be submitted through the Cancer Nanotechnology submission system. To ensure that you submit to the correct thematic series please select the appropriate thematic series in the drop-down menu upon submission. In addition, indicate within your cover letter that you wish your manuscript to be considered as part of the thematic series on Prostate Cancer. All submissions will undergo rigorous peer review and accepted articles will be published within the journal as a collection.

Submissions will also benefit from the usual advantages of open access publication:

  • Rapid publication: Online submission, electronic peer review and production make the process of publishing your article simple and efficient.
  • High visibility and international readership in your field: Open access publication ensures high visibility and maximum exposure for your work - anyone with online access can read your article
  • No space constraints: Publishing online means unlimited space for figures, extensive data and video footage

Authors retain copyright, licensing the article under a Creative Commons license: articles can be freely redistributed and reused as long as the article is correctly attributed.

Sign up to article alerts to keep updated on articles published in Cancer Nanotechnology - including articles published in this thematic series!